US Patent 10399996 Beta-lactamase inhibitors
Patent 10399996 was granted and assigned to Venatorx Pharmaceuticals Inc. on September, 2019 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 10399996 Beta-lactamase inhibitors
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
